Skip to main content
padlock icon - secure page this page is secure

Banana as Edible Vaccine Asgainst Hepatitis-B: A Theoretical Model

Buy Article:

$68.00 + tax (Refund Policy)

Background: Hepatitis B is a disease which has caused major loss of life over the years. The treatment for the disease is very expensive and cure rate is less. Due to its high cost developing or underdeveloped countries are far out of reach from treatment to hepatitis B. There are vaccines produced against this disease but its cost has limited the use by the masses. In the recent years the plant based vaccines called edible vaccines which are cheap compared to the traditional vaccines have been current area of research.

Objective: Edible vaccines using banana have been prepared for Hepatitis B but in this hypothetical paper we have put forward our idea on preparing edible banana vaccine for Hepatitis B thorough a different methodology.

Theoretical Model: We hypothesised to increase the expression level of the transgene by using pBIN19 as a vector instead of traditional Agrobacterium Ti plasmid. The paper also focuses on mechanism of the mode of action of vaccine along with advantages, disadvantages, challenges and future prospects of edible banana vaccine.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Banana; Hepatitis B; edible vaccine; genetic engineering; pBIN19; r-DNA technology

Document Type: Research Article

Publication date: June 1, 2016

More about this publication?
  • Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in the medicinal chemistry and rational drug design for the discovery of new Immunology, Endocrine & Metabolic Agents. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in Immunology, Endocrine & Metabolic medicinal chemistry.

    Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in Immunology, Endocrine & Metabolic drug discovery.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more